GLG News by Physicians who Treat Arrhythmia (US)

This is an abuse of medication - what we don't need

Ruling not unreasonable, but may cause confusion to patients.

This article implies that physician's have no justifiable reason for prescribing brand-name drugs. Unfortunately, it's not that simple.

There is a question of bias in this study. It is not prospective, not randomized and not blinded and thus no valid conclusions can be made. The study should be ignored. It will have no impact on sales.

While most doctors in the past recommended brand-name medications for many reasons, the shift is more towards generic medications.

The Medicare drug system was a political ploy. This just confrims it. The private insurers were unwilling to offer Rx coverage before then because they understood the economics of it.

If truly an association, this will alter the use of this drug.

Once again, we see that medications in most cases are as effective as stenting.  This is old news dating back to the CASS trial in the 1970's and 1980's. Every time we come up with a slick new device we test it against the standard of care and it comes up more expensive and no more effective. ...

As the market for branded statins dries up slowly now with generic simvastatin and lipitor poised for the same fate, the fixed dose combos are the only salvation for the branded drugs.  Abbott has failed to capitalize on the fact that they have the only safe effective and approved drug for raising...

DDP4 inhibitor class fairly new.  Another arrow in the theraputic quiver